IL-17 A/F heterologous polypeptides and therapeutic uses thereof

Details for Australian Patent Application No. 2008229758 (hide)

Owner Genentech, Inc.

Inventors Arnott, David; Gurney, Austin; Hass, Philip; Lee, James; Wu, Yan

Agent Griffith Hack

Pub. Number AU-B-2008229758

Parent 2004259638

Filing date 2 October 2008

Wipo publication date 6 November 2008

Acceptance publication date 26 July 2012

International Classifications

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C07K 14/54 Peptides having more than 20 amino acids

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/24 Mutation or genetic engineering

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 38/00 Medicinal preparations containing peptides

Event Publications

30 October 2008 Complete Application Filed

6 November 2008 Application Open to Public Inspection

  Published as AU-B-2008229758

26 July 2012 Application Accepted

  Published as AU-B-2008229758

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008229759-Methods and compounds for inhibiting amyloid deposits

2008229757-Conduit System